These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35222525)
1. Construction and Verification of a Combined Hypoxia and Immune Index for Clear Cell Renal Cell Carcinoma. Wang B; Liu L; Wu J; Mao X; Fang Z; Chen Y; Li W Front Genet; 2022; 13():711142. PubMed ID: 35222525 [TBL] [Abstract][Full Text] [Related]
2. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
3. Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma. Wu X; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L Front Oncol; 2023; 13():1162846. PubMed ID: 38023248 [TBL] [Abstract][Full Text] [Related]
4. Construction of Competitive Endogenous RNA Network and Verification of 3-Key LncRNA Signature Associated With Distant Metastasis and Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Su Y; Zhang T; Tang J; Zhang L; Fan S; Zhou J; Liang C Front Oncol; 2021; 11():640150. PubMed ID: 33869028 [TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients. Yang H; Han M; Li H Front Oncol; 2020; 10():707. PubMed ID: 32432045 [No Abstract] [Full Text] [Related]
6. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients. Li Z; Du G; Zhao R; Yang W; Li C; Huang J; Wen Z; Li H; Zhang B Medicine (Baltimore); 2021 Oct; 100(39):e27374. PubMed ID: 34596153 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma. Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma. Huang Y; Guo W; Zeng Y; Wang X; Fan B; Zhang Y; Yan L; Gu G; Liu Z Front Oncol; 2024; 14():1354049. PubMed ID: 38454924 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analyses of A 12-metabolism-associated gene signature and its connection with tumor metastases in clear cell renal cell carcinoma. Tan D; Miao D; Zhao C; Shi J; Lv Q; Xiong Z; Yang H; Zhang X BMC Cancer; 2023 Mar; 23(1):264. PubMed ID: 36949462 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of m Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874 [TBL] [Abstract][Full Text] [Related]
11. Expression of basement membrane genes and their prognostic significance in clear cell renal cell carcinoma patients. Tao J; Li X; Liang C; Liu Y; Zhou J Front Oncol; 2022; 12():1026331. PubMed ID: 36353536 [TBL] [Abstract][Full Text] [Related]
12. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma. Ma S; Ge Y; Xiong Z; Wang Y; Li L; Chao Z; Li B; Zhang J; Ma S; Xiao J; Liu B; Wang Z PeerJ; 2023; 11():e14784. PubMed ID: 36785707 [TBL] [Abstract][Full Text] [Related]
13. Identification of an independent immune-genes prognostic index for renal cell carcinoma. Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413 [TBL] [Abstract][Full Text] [Related]
14. Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma. Ma W; Zhong M; Liu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34402862 [TBL] [Abstract][Full Text] [Related]
15. Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients. Yao J; Liang Z; Duan L; G Y; Liu J; An G Heliyon; 2023 Jun; 9(6):e15925. PubMed ID: 37484396 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma. Lv Z; Qi L; Hu X; Mo M; Jiang H; Li Y Front Oncol; 2021; 11():633950. PubMed ID: 33816274 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma. Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382 [TBL] [Abstract][Full Text] [Related]
18. Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma. Liu C; Zhang X; Hu C; Liang X; Cao X; Wang D Front Genet; 2022; 13():877656. PubMed ID: 35774505 [No Abstract] [Full Text] [Related]
19. Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma. Zhang C; Zeng J; Ye C; Tian K; Xian Z Transl Cancer Res; 2024 Jan; 13(1):150-172. PubMed ID: 38410230 [TBL] [Abstract][Full Text] [Related]
20. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma. Zhang L; Su Z; Hong F; Wang L Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]